Avior Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-84
Closed -$19.2K 1983
2024
Q4
$19.2K Sell
84
-32
-28% -$7.71K ﹤0.01% 1420
2024
Q3
$28.3K Sell
116
-257
-69% -$57.4K ﹤0.01% 1297
2024
Q2
$71.4K Buy
373
+126
+51% +$25.6K ﹤0.01% 973
2024
Q1
$48.9K Buy
247
+233
+1,664% +$42.7K ﹤0.01% 1243
2023
Q4
$2.41K Sell
14
-9
-39% -$1.38K ﹤0.01% 1280
2023
Q3
$3.4K Sell
23
-4
-15% -$723 ﹤0.01% 1302
2023
Q2
$5.9K Buy
27
+23
+575% +$5.13K ﹤0.01% 1128
2023
Q1
$875 Hold
4
﹤0.01% 1470
2022
Q4
$832 Hold
4
﹤0.01% 1137
2022
Q3
$0 Hold
4
﹤0.01% 1270
2022
Q2
$0 Hold
4
﹤0.01% 1202
2022
Q1
$0 Hold
4
﹤0.01% 1214
2021
Q4
$1K Sell
4
-2
-33% -$519 ﹤0.01% 1044
2021
Q3
$1K Hold
6
﹤0.01% 1017
2021
Q2
$1K Buy
6
+1
+20% +$210 ﹤0.01% 991
2021
Q1
$0 Hold
5
﹤0.01% 1119
2020
Q4
$1K Hold
5
﹤0.01% 940
2020
Q3
$0 Hold
5
﹤0.01% 1007
2020
Q2
$0 Sell
5
-2
-29% -$327 ﹤0.01% 978
2020
Q1
$1K Hold
7
﹤0.01% 742
2019
Q4
$1K Hold
7
﹤0.01% 766
2019
Q3
$0 Hold
7
﹤0.01% 854
2019
Q2
$1K Buy
+7
New +$775 ﹤0.01% 807

Other funds holding RMD

Avior Wealth Management's RMD Position: Q1 2025 in Review

Avior Wealth Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 84 shares — an estimated $19.2K sold.

Avior Wealth Management first reported a position in RMD in Q2 2019 and held it in 23 quarters. The position peaked at $71.4K in Q2 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Avior Wealth Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 84 ResMed shares in Q1 2025, an estimated $19.2K.
  • Avior Wealth Management first reported a position in ResMed in Q2 2019 and held it in 23 quarters.
  • Avior Wealth Management's ResMed position peaked at $71.4K in Q2 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.